Skip to main content
INVA logo

Innoviva, Inc.

INVANASDAQHealthcareBiotechnology

$20.66Today:- (-)1Y +15.33%

As of Oct 23, 2026 close

Market cap
$1.52B
P/E (TTM)
4.25
Forward P/E
2.42
Dividend yield
-
52-week range
$17.13$25.15
Volume (live)
-
Avg. volume (3M)
895.89K

Innoviva (INVA) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Innoviva generated $196.93M of operating cash flow and spent $10.50M on capital expenditures. That left free cash flow of $186.43M, up 1.1% from $184.42M a year earlier, or 45.3% of revenue. It repurchased $4.67M of its own shares.

Innoviva Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Innoviva, Inc. (INVA) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income271.1723.39179.72220.26368.84224.40190.99406.33134.27
Depreciation & Amortization26.2825.9035.715.5813.830.0213.8713.8713.98
Deferred Income Tax43.85-12.624.4025.0176.4360.4241.88-196.057.15
Stock Based Compensation9.456.375.847.352.021.702.063.239.83
Change in Working Capital-24.16-6.93-24.796.87-16.87-14.323.10-16.76-28.28
Change in Accounts Receivable-6.95-2.29-20.009.79-16.78-14.503.86-12.75-23.69
Change in Inventory-12.92-6.81-12.000.280.000.00-0.66-3.430.00
Change in Accounts Payable6.8936.893.7810.12-0.040.060.00-0.590.47
Change in Other Working Capital22.5829.164.9629.41-0.050.13-0.100.00-5.06
Other Operating Activities22.5829.16-55.4129.41-80.43129.725.5712.914.79
Net Cash from Operating Activities196.93188.69141.06201.73363.81313.11257.46223.53141.75
Investing Activities
Capital Expenditures-10.50-4.27-0.41-0.07-1.30-0.01-0.010.000.00
Acquisitions28.16-32.27-31.16-265.01-235.81-102.8617.990.000.00
Purchases of Investments-78.40-103.10-97.51-87.1022.28-314.92-231.92-71.86-67.62
Sales/Maturities of Investments101.2275.7672.5056.63279.5386.00213.9275.3844.39
Other Investing Activities-9.36-43.49-41.34-56.63-20.980.00-17.990.000.00
Net Cash from Investing Activities40.50-63.79-66.76-56.6343.72-314.94-18.003.52-23.24
Financing Activities
Debt Repayment-0.030.00-96.20-165.130.000.00-13.75-230.00-63.74
Common Stock Issued2.551.470.170.371.170.440.631.140.44
Common Stock Repurchased-4.68-14.92-75.81-8.59-394.21-0.09-0.09-3.07-99.63
Dividends Paid0.000.000.000.000.000.00-0.01-0.08-0.28
Other Financing Activities-0.030.000.00-134.76-59.46-30.13-10.55-5.960.02
Net Cash from Financing Activities8.55-13.45-171.84-55.57-452.50-29.79-23.78-237.97-163.19
Summary
Net Change in Cash245.98111.45-97.5489.52-44.96-31.61215.68-10.92-44.68
Cash at Beginning of Period304.96193.51291.05201.53246.49278.1062.4273.34118.02
Cash at End of Period550.94304.96193.51291.05201.53246.49278.1062.4273.34
Free Cash Flow186.43184.42140.65201.66362.51313.10257.45223.53141.75
Supplemental Disclosures
Interest Paid-10.3611.3811.749.939.93---
Income Taxes Paid-11.79-53.86-----

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Innoviva Cash Flow

What is Innoviva's free cash flow?

Innoviva generated free cash flow of $186.43M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of $196.93M minus $10.50M of capital expenditures. That was up 1.1% from $184.42M a year earlier. Free cash flow equaled 45.3% of revenue.

How much does Innoviva spend on capital expenditures?

Innoviva spent $10.50M on capital expenditures in fiscal 2025, compared with $4.27M a year earlier. That equals 5.3% of operating cash flow.

Does Innoviva pay dividends or buy back shares?

Yes. In fiscal 2025 Innoviva returned $4.67M in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition